Literature DB >> 3064097

Antibody toxin conjugates: a perspective.

D C Blakey, E J Wawrzynczak, P M Wallace, P E Thorpe.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3064097

Source DB:  PubMed          Journal:  Prog Allergy        ISSN： 0079-6034


× No keyword cloud information.
  10 in total

1.  Infectious enveloped RNA virus antigenic chimeras.

Authors:  S D London; A L Schmaljohn; J M Dalrymple; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 2.  Monoclonal antibodies. Future potential in cancer chemotherapy.

Authors:  C Kosmas; H Kalofonos; A A Epenetos
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

3.  Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.

Authors:  E J Wawrzynczak; G J Watson; A J Cumber; R V Henry; G D Parnell; E P Rieber; P E Thorpe
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Different cytotoxic activity and intracellular fate of an anti-CD5-momordin immunotoxin in normal compared to tumour cells.

Authors:  G Porro; P Lento; F Marcucci; G Gromo; D Modena
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

5.  Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.

Authors:  M Better; S L Bernhard; S P Lei; D M Fishwild; J A Lane; S F Carroll; A H Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 6.  Bispecific antibody: a tool for diagnosis and treatment of disease.

Authors:  S Songsivilai; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

7.  Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide.

Authors:  D E Kerr; P D Senter; W V Burnett; D L Hirschberg; I Hellström; K E Hellström
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 8.  Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS.

Authors:  E S Vitetta
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

9.  Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates.

Authors:  D M Fishwild; H M Wu; S F Carroll; S L Bernhard
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  T lymphocyte killing by a xanthine-oxidase-containing immunotoxin.

Authors:  M G Battelli; A Abbondanza; P L Tazzari; A Bolognesi; R M Lemoli; F Stirpe
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.